Effect of Bevacizumab on Human Corneal Endothelial Cells: A Six-month Follow-up Study
- 30 November 2008
- journal article
- Published by Elsevier BV in American Journal of Ophthalmology
- Vol. 146 (5), 688-691.e2
- https://doi.org/10.1016/j.ajo.2008.06.002
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Effect of anti-VEGF antibody on retinal ganglion cells in ratsBritish Journal of Ophthalmology, 2007
- VISUAL IMPROVEMENT FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- Effects of bevacizumab on retinal function in isolated vertebrate retinaBritish Journal of Ophthalmology, 2006
- Antiproliferative and cytotoxic properties of bevacizumab on different ocular cellsBritish Journal of Ophthalmology, 2006
- SHORT-TERM SAFETY AND EFFICACY OF INTRAVITREAL BEVACIZUMAB (AVASTIN) FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONRetina, 2006
- TESTING INTRAVITREAL TOXICITY OF BEVACIZUMAB (AVASTIN)Retina, 2006
- ELECTROPHYSIOLOGIC AND RETINAL PENETRATION STUDIES FOLLOWING INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN)Retina, 2006
- ELECTROPHYSIOLOGIC FINDINGS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) TREATMENTRetina, 2006
- THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN OCULAR HEALTH AND DISEASERetina, 2005
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerThe New England Journal of Medicine, 2004